Fundacion de Investigacion (FDI)
San Juan 00927-4807
0 studies enrolling now · 2 studies all time
What they study most
Non Alcoholic Steatohepatitis (NASH)
Studies at this site
- A Phase 2b Study of Icosabutate in Fatty Liver Disease — Completed
- Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis — Status unconfirmed